http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111214450-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f41ad3e3eb895fb77774c608c6e8eeb7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_097b2f0b485c8ae49898a70982c12f67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7e2b9a11a3f71d165e7dd72230437a5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
filingDate 2020-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1be79beb141a11bdddf0c13f19c98c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5690589fd8d0723ecaef51f709217461
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41950ba36d6cf79259095c7f3486819d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46b8232d9d9c688c437250dfd2c04505
publicationDate 2020-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111214450-A
titleOfInvention Empagliflozin tablet and its preparation process
abstract The invention provides an empagliflozin tablet and a preparation process thereof, comprising empagliflozin, a carrier material and other pharmaceutically acceptable excipients, characterized in that the carrier material is composed of poloxamer and mannitol together . The preparation process of the empagliflozin tablet disclosed by the invention is simple to operate, and has the characteristics of fast dissolution rate, good stability and the like.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112557533-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112618495-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112618495-A
priorityDate 2020-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016051368-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14049689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496486
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6435831
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421421992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11949646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426208976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426106613

Total number of triples: 49.